Condition category
Signs and Symptoms
Date applied
27/06/2007
Date assigned
27/06/2007
Last edited
21/09/2007
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr C. Keijzer

ORCID ID

Contact details

Netherlands Cancer Institute (NKI)
Plesmanlaan 121
Amsterdam
1066 CX
Netherlands
+31 (0)20 512 9111
c.keijzer@nki.nl

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

Study hypothesis

The purpose of this study is to register the average Carbon monoxide (CO) concentrations in forty patients receiving desflurane or sevoflurane anaesthesia after implementation of a safety protocol to prevent desiccation of the strong base containing absorbent Drägersorb 800 Plus®.

Ethics approval

Ethics approval received from the local medical ethics committee

Study design

Observational, case-control study

Primary study design

Observational

Secondary study design

Case-control study

Trial setting

Hospitals

Trial type

Screening

Patient information sheet

Condition

Anaesthesia

Intervention

Desflurane or sevoflurane anaesthesia.

Intervention type

Drug

Phase

Not Specified

Drug names

Desflurane, sevoflurane

Primary outcome measures

Amount of carbon monoxide or compound A produced.

Secondary outcome measures

No secondary outcome measures

Overall trial start date

01/08/2005

Overall trial end date

01/10/2006

Reason abandoned

Eligibility

Participant inclusion criteria

1. Non-smoking patients
2. American Society of Anaesthesiologists physical status class 1 to 3
3. Scheduled for a surgical procedure that would last at least ninety minutes

Participant type

Patient

Age group

Adult

Gender

Not Specified

Target number of participants

40

Participant exclusion criteria

1. Younger than 18 years of age
2. Suffering from terminal renal failure

Recruitment start date

01/08/2005

Recruitment end date

01/10/2006

Locations

Countries of recruitment

Netherlands

Trial participating centre

Netherlands Cancer Institute (NKI)
Amsterdam
1066 CX
Netherlands

Sponsor information

Organisation

Vrije University Medical Centre (VUMC) (The Netherlands)

Sponsor details

Department of Anesthesiology
P.O. Box 7057
Amsterdam
1007 MB
Netherlands

Sponsor type

Hospital/treatment centre

Website

http://www.vumc.nl/english/

Funders

Funder type

Hospital/treatment centre

Funder name

Vrije University Medical Centre (VUMC) (The Netherlands)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes